Tag: D2 Gas

Daniel Mateos Appointed Chief Technology Officer

Posted on

Mateos to lead the development of new deuterium products, technologies and projects.

We are pleased to announce that Daniel Mateos has been appointed Chief Technology Officer at deutraMed. Daniel brings more than 25 years of international experience in technology, engineering and project execution

In his new role, Daniel will lead the development of new deuterium products, technologies and projects at our company. He is also responsible for new product and technology development and project execution across the Key DH Technologies group of companies, which includes deutraMed, Isowater and Hydrogen Optimized.

Daniel leads a multi-disciplinary team of engineers and scientists that is focused both on technology commercialization and project execution. At deutraMed, he will focus on advancing technologies and processes to meet the growing demand for value-added deuterium-containing ingredients used mainly in the Life Sciences and High Technology sectors. He brings a high level of energy and experience in building dynamic cross-functional teams and advancing technologies to bring new products to customers.

Daniel served most recently as the company’s Director of Business Development and Sales – Europe, a position focused on developing customer relationships and sales opportunities across Europe.

Throughout his career, Daniel has contributed significantly to the development of new business opportunities and products in the chemical industry, industrial gases, green hydrogen, clean energy and other fields. His experience includes work at leading German and Spanish international companies involved in the engineering and construction of plants for the oil, gas and chemical industries, among others at Linde and Tecnicas Reunidas. He holds several patents in these fields.

Daniel earned a degree in Engineering (Master’s equivalent) from the Polytechnic University UPM Madrid in Spain, and a specialization in Process and Chemical Engineering at the Technical University RWTH Aachen in Germany. He is fluent in German, English and Spanish.

White text against a red background that reads "deutraMed's Steven Bovair to Attend Electronic Specialty Gas & Systems Conference Oct. 22-24" with deutraMed gas canisters to the right.

deutraMed’s Steven Bovair to Attend Electronic Specialty Gas & Systems Conference, Oct. 22-24

Posted on

deutraMed® is attending the 2024 Electronic Specialty Gas & Systems (ESGS) Conference at Wild Horse Pass in Chandler, Arizona. Steven Bovair, Sales Manager, will represent the company at the annual event, which takes place October 22-24, 2024.

deutraMed® is a leading global supplier of deuterium (D2) gas, which is used globally in the fabrication of semiconductors and fibre optics. We work directly with customers who are actively seeking to recover deuterium from end-use applications for re-enrichment and reuse. deutraMed’s re-enrichment process significantly reduces the need to rely on new supplies of deuterium oxide, the raw material used to produce the deuterium gas that is used in semiconductor manufacturing.

Most deuterium oxide available in the market today is produced with energy-intensive processes that depend heavily on electricity from coal-fired power plants. The recovery and re-enrichment of deuterium gas would provide a significant sustainability benefit by capturing gas with a Global Warming Potential (GWP) up to 15 times that of CO2 – a GWP that is equivalent to methane. Further, it can react with and amplify the GWP of fluoro-compounds with a GWP thousands of times higher than CO2. It is therefore important to continue R&D around the capture, recovery and reuse of D2 gas.

The ESGS conference focuses on the market, technology trends and market drivers for electronic gases. This includes developments in the bulk, rare and specialty gas markets that are critical to the continued growth of the electronics industry. The conference, a gathering place for executives, buyers, product managers, and strategic planners from the electronic gases value chain, features industry experts with insights on key developments and challenges in this market.

To connect with Steven Bovair, please send an email to sales@deutramed.com.

More information about the conference can be found here.